This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
THOUSAND OAKS, Calif.,
Nov. 20, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 24
th Annual Piper Jaffray Healthcare Conference on
Wednesday, Nov. 28, 2012, at the New York Palace hotel in
New York City, beginning at
11:30 a.m. Eastern Standard Time.
Arvind Sood, vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website,
www.amgen.com, under Investors.
About AmgenAmgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit
www.amgen.com. Follow us on